unknown
Stage
About
GoodCap Pharmaceuticals develops novel drug candidates targeting neuroinflammatory diseases, focusing on treating PTSD and other psychiatric and neurodegenerative disorders through proprietary molecular combinations.
Explore GoodCap's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.